Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Quidel Corporation (NasdaqNM:QDEL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider | Reports
Location
10165 McKeller Court
San Diego, CA 92121
Phone: (858) 552-1100
Fax: (858) 453-4338
Email: webguru@quidel.com
Employees (last reported count): 350
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Products & Services
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 26%
·Over the last 6 months:
 · 2 insider buys; 12.0K shares (0.2% of insider shares)
 · 4 insider sells; 126.0K shares
  (1.7% of insider shares)
·Institutional: 35% (48% of float)
(38 institutions)
·Net Inst. Buying: 278.0K shares (+2.70%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Quidel Corporation develops, manufactures and markets point-of-care (POC) rapid diagnostic tests for the detection and management of a variety of medical conditions and illnesses. These products provide healthcare professionals and consumers with accurate and cost-effective diagnostic information at the POC. The Company's products are sold to professionals for use in physician's offices, hospitals, clinical laboratories and wellness screening centers. The Company also manufactures a line of products sold to consumers through distribution partners and organizations that provide store-branded products. Its products are substantially focused on women and family health in areas such as reproduction, infectious diseases, general health screening and diseases associated with the elderly.
More from Market Guide: Expanded Business Description

Financial Summary
Quidel develops, manufactures, and markets rapid immunodiagnostic products which provide diagnoses in the areas of reproductive and women's health, infectious diseases, allergies, and autoimmune disorders. For the six months ended 6/30/01, revenues decreased 8% to $35.1 million. Net loss before acct. change totalled $449 thousand vs. income of $864 thousand. Results reflect decreased unit sales, and $550 thousand in restructuring charges.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Andre De Bruin, 53
Chairman
$295K
S. Wayne Kay
Pres, CEO
--  
Paul Landers
CFO, VP
--  
Linda Haelewyn
Sr. VP, Global Commercial Operations
--  
Mark Paiz, 38
Sr. VP, Product Devel. and Supply Operations
160K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:QDELAs of 31-Aug-2001
Price and Volume
52-Week Low
on 3-Apr-2001
$2.875
Recent Price$4.85 
52-Week High
on 6-Nov-2000
$7.25 
Beta0.36 
Daily Volume (3-month avg)47.6K
Daily Volume (10-day avg)36.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-24.7%
52-Week Change
relative to S&P500
+1.1%
Share-Related Items
Market Capitalization$136.8M
Shares Outstanding28.2M
Float20.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.04 
Earnings (ttm)-$0.26 
Earnings (mrq)-$0.03 
Sales (ttm)$2.39 
Cash (mrq)$0.05 
Valuation Ratios
Price/Book (mrq)2.38 
Price/EarningsN/A 
Price/Sales (ttm)2.03 
Income Statements
Sales (ttm)$64.4M
EBITDA (ttm)-$3.02M
Income available to common (ttm)-$6.47M
Profitability
Profit Margin (ttm)-10.0%
Operating Margin (ttm)-11.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-8.69%
Return on Equity (ttm)-12.20%
Financial Strength
Current Ratio (mrq)2.32 
Debt/Equity (mrq)0.26 
Total Cash (mrq)$1.53M
Short Interest
As of 8-Aug-2001
Shares Short31.0K
Percent of Float0.1%
Shares Short
(Prior Month)
38.0K
Short Ratio0.66 
Daily Volume47.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.